Santa Cruz Biotechnology offers a broad range of SARS Antibodies for the detection and analysis of SARS-CoV proteins. SARS Antibodies are suitable for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SARS-CoV proteins are integral to the virus's life cycle, facilitating viral entry, replication, and immune evasion mechanisms. Research focused on SARS-CoV proteins continues to be vital for developing therapeutic strategies and vaccines against SARS and related coronaviruses. The investigation of SARS-CoV proteins enhances our understanding of viral pathogenesis and host-pathogen interactions. Researchers worldwide rely on highly specific monoclonal antibodies to uncover new insights into coronavirus biology. Advanced research techniques supported by monoclonal antibodies enable detailed characterization of viral protein functions and interactions. The comprehensive selection of SARS monoclonal antibodies from Santa Cruz Biotechnology empowers researchers to make significant contributions to virology and infectious disease research.